Organic anion transporting polypeptides (OATPs): Regulation of expression and function

Current Drug Metabolism

Volumn 12, Issue 2, 2011, Pages 139-153

  Svoboda, Martin ^a   Riha, Juliane ^b   Wlcek, Katrin ^a,b   Jaeger, Walter ^b   Thalhammer, Theresia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Animal models; OATP; Regulation; SLCO; Structure; Transporter

Indexed keywords

CELL NUCLEUS RECEPTOR; CLOTRIMAZOLE; CYCLOSPORIN; DIGOXIN; ENDOTOXIN; ESTRADIOL 17 GLUCURONIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEMBRANE PROTEIN; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1A2; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1B3; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1C1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 2A1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 2B1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 3A1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 4A1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 4C1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 5A1; ORGANIC ANION TRANSPORTING POLYPEPTIDE 6A1; RIFAMPICIN; SAQUINAVIR; SEX HORMONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL LINE; CHOLESTASIS; DNA METHYLATION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TRANSPORT; EPIGENETICS; HUMAN; MEMBRANE TRANSPORT; NONHUMAN; PDZ DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REGULATORY MECHANISM; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CHOLESTASIS; CYTOKINES; DNA METHYLATION; GENE EXPRESSION REGULATION; GONADAL STEROID HORMONES; HUMANS; LIVER; MODELS, ANIMAL; MODELS, BIOLOGICAL; ORGANIC ANION TRANSPORTERS; PDZ DOMAINS; PHARMACEUTICAL PREPARATIONS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SEQUENCE ALIGNMENT; TOXINS, BIOLOGICAL;

EID: 79952809873     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920011795016863     Document Type: Article

References (148)

1. Dobson, P.D.; Lanthaler, K.; Oliver, S.G.; Kell, D.B. Implications of the dominant role of transporters in drug uptake by cells. Curr. Top. Med. Chem., 2009, 9(2), 163-181.
2. Hediger, M.A.; Romero, M.F.; Peng, J.B.; Rolfs, A.; Takanaga, H.; Bruford, E.A. The ABCs of solute carriers: Physiological, pathological and therapeutic implications of human membrane transport proteins. Pflugers Arch., 2004, 447(5), 465-468. (Pubitemid 38241432)
3. Hagenbuch, B.; Meier, P.J. Organic anion transporting polypeptides of the OATP/SLC21 family: Phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/ functional properties. Pflugers Arch., 2004, 447(5), 653-665. (Pubitemid 38241451)
4. Hagenbuch, B.; Meier, P.J. The superfamily of organic anion transporting polypeptides. Biochim. Biophys. Acta., 2003, 1609(1), 1-18. (Pubitemid 36044060)
5. Meier-Abt, F.; Mokrab, Y.; Mizuguchi, K. Organic anion transporting polypeptides of the OATP/SLCO superfamily: Identification of new members in non-mammalian species, comparative modeling and a potential transport mode. J. Membr. Biol., 2005, 208, 213-227.
6. Mikkaichi, T.; Suzuki, T.; Tanemoto, M.; Ito, S.; Abe, T. The organic anion transporter (OATP) family. Drug Metab. Pharmacokinet., 2004, 19, 171-179.
7. Hagenbuch, B.; Gui, C. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica, 2008, 38(7-8), 778-801.
8. Pao, S.S.; Paulsen, I.T.; Saier, M.H. Jr. Major facilitator superfamily. Microbiol. Mol. Biol. Rev., 1998, 62(1), 1-34. (Pubitemid 28130794)
9. Saier, M.H. Jr; Yen, M.R.; Noto, K.; Tamang, D.G.; Elkan, C. The Transporter Classification Database: Recent advances. Nucleic Acids Res., 2009, 37, D274-278.
10. Transporter homepage (http://www.tcdb.org)
11. Tirona, R.G.; Kim, R.B. Pharmacogenomics of organic aniontransporting polypeptides (OATP). Adv. Drug Deliv. Rev., 2002, 54(10), 1343-1352. (Pubitemid 35291071)
12. Hakes, D.J.; Berezney, R. Molecular cloning of matrin F/G: A DNA binding protein of the nuclear matrix that contains putative zinc finger motifs. Proc. Natl. Acad. Sci. U S A, 1991, 15, 88(14), 6186-6190. (Pubitemid 21914911)
13. Hänggi, E.; Grundschober, A.F.; Leuthold, S.; Meier, P.J.; St- Pierre, M.V. Functional analysis of the extracellular cysteine residues in the human organic anion transporting polypeptide, OATP2B1. Mol. Pharmacol., 2006, 70, 806-817. (Pubitemid 44268438)
14. Barabote, R.D.; Tamang, D.G.; Abeywardena, S.N.; Fallah, N.S.; Fu, J.Y.; Lio, J.K.; Mirhosseini, P.; Pezeshk, R.; Podell, S.; Salampessy, M.L.; Thever, M.D.; Saier, M.H. Jr. Extra domains in secondary transport carriers and channel proteins. Biochim. Biophys. Acta., 2006, 1758, 1557-1579. (Pubitemid 44466705)
15. Ogura, K.; Choudhuri, S.; Klaassen, C.D. Full-length cDNA cloning and genomic organization of the mouse liver-specific organic anion transporter-1 (lst-1). Biochem. Biophys. Res. Commun., 2000, 272(2), 563-570. (Pubitemid 30444656)
16. Schlott, B.; Wöhnert, J.; Icke, C.; Hartmann, M.; Ramachandran, R.; Gührs, K.H.; Glusa, E.;Flemming, J.; Görlach, M.; Grosse, F.; Ohlenschläger, O. Interaction of Kazal-type inhibitor domains with serine proteinases: Biochemical and structural studies. J. Mol. Biol., 2002, 318(2), 533-546. (Pubitemid 34734845)
17. Rawlings, N.D.; Tolle, D.P.; Barrett, A.J. Evolutionary families of peptidase inhibitors. Biochem. J., 2004, 378(3), 705-716. (Pubitemid 38406845)
18. Zheng, Q.L.; Sheng, Q.; Zhang, Y.Z. Progresses in the structure and function of Kazal-type proteinase inhibitors. Sheng Wu Gong Cheng Xue Bao, 2006, 22, 695-700.
19. Lee, H.J.; Zheng, J.J. PDZ domains and their binding partners: Structure, specificity, and modification. Cell Commun. Signal. , 2010, 8, 8.
20. Wang, P.; Wang, J.J.; Xiao, Y.; Murray, J.W.; Novikoff, P.M.; Angeletti, R.H.; Orr, G.A.; Lan, D.; Silver. D.L.; Wolkoff, A.W. Interaction with PDZK1 is required for expression of organic anion transporting protein 1A1 on the hepatocyte surface. J. Biol. Chem., 2005, 280, 30143-30149. (Pubitemid 41216192)
21. Kato, Y.; Yoshida, K.; Watanabe, C.; Sai, Y; Tsuji, A. Screening of the interaction between xenobiotic transporters and PDZ proteins. Pharm. Res., 2004, 21, 1886-1894. (Pubitemid 39390102)
22. Bao, Y.; Pucci, M.L.; Chan, B.S.; Lu, R.; Ito, S.; Schuster, V.L. Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids. Am. J. Physiol. Renal. Physiol., 2002, 282(6), F1103-1110. (Pubitemid 34654476)
23. Shitara, Y.; Sato, H.; Sugiyama, Y. Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu. Rev. Pharmacol. Toxicol., 2005, 45, 689-723. (Pubitemid 40261822)
24. Kalliokoski, A.; Niemi, M. Impact of OATP transporters on pharmacokinetics. Br. J. Pharmacol., 2009, 158, 693-705.
25. Fahrmayr, C.; Fromm, M.F.; König, J. Hepatic OATP and OCT uptake transporters: Their role for drug-drug interactions and pharmacogenetic aspects. Drug. Metab. Rev., 2010, 42(3):380-401.
26. Satlin, L.M.; Amin, V.; Wolkoff, A.W. Organic anion transporting polypeptide mediates organic anion/HCO3- exchange. J. Biol. Chem., 1997, 272(42), 26340-26345. (Pubitemid 27458848)
27. Li, L.; Lee, T.K.; Meier, P.J.; Ballatori, N. Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J. Biol. Chem., 1998, 273(26), 16184-91. (Pubitemid 28311391)
28. Briz, O.; Serrano, M.A.; MacIas, R.I.; Gonzalez-Gallego, J.; Marin, J.J. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin. Biochem. J.,2003, 371(3), 897-905. (Pubitemid 36578888)
29. Nozawa, T.; Imai, K.; Nezu, J.; Tsuji, A.; Tamai, I. Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J. Pharmacol. Exp. Ther., 2004, 308(2), 438-445. (Pubitemid 38134202)
30. Mahagita, C.; Grassl, S.M.; Piyachaturawat, P.; Ballatori, N. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 293(1), G271-278. (Pubitemid 47105195)
31. Kanai, N.; Lu, R.; Bao, Y.; Wolkoff A.W.; Schuster, V.L. Transient expression of oatp organic anion transporter in mammalian cells: Identification of candidate substrates. Am. J. Physiol., 1996, 270 (2), F319-25.
32. Kobayashi, D.; Nozawa, T.; Imai, K.; Nezu, J.; Tsuji, A.; Tamai, I. Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J. Pharmacol. Exp. Ther., 2003, 306(2), 703-708. (Pubitemid 36886171)
33. Leuthold, S.; Hagenbuch, B.; Mohebbi, N.; Wagner, C.A.; Meier, P.J.; Stieger, B. Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. Am. J. Physiol. Cell Physiol., 2009, 296, C570-582.
34. Kim, RB. Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur. J. Clin. Invest., 2003, 33, (2), 1-5.
35. Mikkaichi, T.; Suzuki, T.; Onogawa, T.; Tanemoto, M.; Mizutamari, H.; Okada, M.; Chaki, T.; Masuda, S.; Tokui, T.; Eto, N.; Abe, M.; Satoh, F.; Unno, M.; Hishinuma, T.; Inui, K.; Ito, S.; Goto, J.; Abe, T. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc. Natl. Acad. Sci. U S A., 2004, 101(10), 3569-3574. (Pubitemid 38338236)
36. Seithel, A.; Glaeser, H.; Fromm, M.F.; König, J. The functional consequences of genetic variations in transporter genes encoding human organic anion-transporting polypeptide family members. Expert. Opin. Drug Metab. Toxicol., 2008, 4(1), 51-64. (Pubitemid 351234100)
37. Kindla, J.; Fromm, M.F.; König, J. In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions. Expert Opin. Drug Metab. Toxicol., 2009, 5(5), 489-500.
38. Glaeser, H.; Bailey, D.G.; Dresser, G.K.; Gregor, J.C.; Schwarz, U.I.; McGrath, J.S.; Jolicoeur, E.; Lee, W.; Leake, B.F.; Tirona, R.G.; Kim, R.B. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin. Pharmacol. Ther., 2007, 81(3), 362-370. (Pubitemid 46364477)
39. Gao, B.; Hagenbuch, B.; Kullak-Ublick, G.A.; Benke, D.; Aguzzi, A.; Meier, P.J. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J. Pharmacol. Exp. Ther., 2000, 294(1), 73-79. (Pubitemid 30434672)
40. Lee, W.; Glaeser, H.; Smith, L.H.; Roberts, R.L.; Moeckel, G.W.; Gervasini, G.; Leake, B.F.; Kim, R.B. Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): Implications for altered drug disposition and central nervous system drug entry. J. Biol. Chem., 2005, 280(10), 9610-9617. (Pubitemid 40409657)
41. Franke, R.M.; Scherkenbach, L.A.; Sparreboom, A. Pharmacogenetics of the organic anion transporting polypeptide 1A2. Pharmacogenomics, 2009, 10(3), 339-344.
42. Abe, T.; Kakyo, M.; Tokui, T.;, Nakagomi, R.; Nishio, T.; Nakai, D.; Nomura, H.; Unno, M.; Suzuki, M.; Naitoh, T.; Matsuno, S.; Yawo, H. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J. Biol. Chem., 1999, 274, 17159-17163.
43. Hsiang, B.; Zhu, Y.; Wang, Z.; Wu, Y.; Sasseville, V.; Yang, W.P.; Kirchgessner, T.G. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J. Biol. Chem., 1999, 274(52), 37161-37168.
44. König, J.; Cui, Y.; Nies, A.T.; Keppler, D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J. Biol. Chem., 2000, 275(30), 23161-23168. (Pubitemid 30646210)
45. König, J.; Cui, Y.; Nies, A.T.; Keppler, D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am. J. Physiol. Gastrointest. Liver Physiol., 2000, 278(1), G156-164. (Pubitemid 30108080)
46. Ieiri, I; Higuchi, S; Sugiyama, Y. Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: Implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and otherclinically relevant drugs. Expert Opin Drug Metab. Toxicol., 2009, 5(7), 703-729.
47. Romaine, S.P.; Bailey, K.M.; Hall, A.S.; Balmforth, A.J. The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy. Pharmacogenomics J., 2010, 10(1), 1-11.
48. Oshiro, C.; Mangravite, L; Klein, T.; Altman, R. PharmGKB-very important pharmacogene: SLCO1B1. Pharmacogenet. Genomics, 2010, 20(3), 211-216.
49. Abe, T.; Unno, M.; Onogawa, T.; Tokui, T.; Kondo, T.N.; Nakagomi, R.; Adachi, H.; Fujiwara, K.; Okabe, M.; Suzuki, T.; Nunoki, K.; Sato, E.; Kakyo, M.; Nishio, T.; Sugita, J.; Asano, N.; Tanemoto, M.; Seki, M.; Date, F.; Ono, K.; Kondo, Y.; Shiiba, K.; Suzuki, M.; Ohtani, H.; Shimosegawa, T.; Iinuma, K.; Nagura, H.; Ito, S.; Matsuno, S. LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterol., 2001, 120(7), 1689-1699. (Pubitemid 32523487)
50. Tsujimoto, M.; Dan, Y.; Hirata, S.; Ohtani, H.; Sawada, Y. Influence of SLCO1B3 gene polymorphism on the pharmacokinetics of digoxin in terminal renal failure. Drug. Metab. Pharmacokinet., 2008, 23(6), 406-411.
51. Cui, Y.; König, J.; Nies, A.T.; Pfannschmidt, M.; Hergt, M.; Franke, W.W.; Alt, W.; Moll, R.; Keppler, D. Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab Invest., 2003, 83 (4), 527-538. (Pubitemid 36457707)
52. Zollner, G.; Wagner, M.; Fickert, P.; Silbert, D.; Fuchsbichler, A.; Zatloukal, K.; Denk, H.; Trauner, M. Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int., 2005, 25(2), 367-379.
53. Muto, M.; Onogawa, T.; Suzuki, T.; Ishida, T.; Rikiyama, T.; Katayose, Y.; Ohuchi, N.; Sasano, H.; Abe, T.; Unno, M. Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma. Cancer Sci., 2007, 98(10), 1570-1576. (Pubitemid 47308452)
54. Hamada, A.; Sissung, T.; Price, D.K.; Danesi, R.; Chau, C.H.; Sharifi, N., Venzon, D.; Maeda, K.; Nagao, K.; Sparreboom, A.; Mitsuya, H.; Dahut, W.L.; Figg, W.D. Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin. Cancer Res., 2008, 14(11), 3312-3318.
55. Lee, W.; Belkhiri, A.; Lockhart, A.C.; Merchant, N.; Glaeser, H.; Harris, E.I.; Washington, M.K.; Brunt, E.M.; Zaika, A.; Kim, R.B.; El-Rifai, W. Overexpression of OATP1B3 confers apoptotic resistance in colon cancer. Cancer Res., 2008, 68(24), 10315-10323.
56. Justenhoven, C.; Schaeffeler, E.; Winter, S.; Baisch, C.; Hamann, U.; Harth, V.; Rabstein S.; Spickenheuer, A.; Pesch, B.; Brüning T.; Ko, Y.D.; Schwab, M.; Brauch, H. Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk. Breast Cancer Res Treat., 2010.
57. Tamai, I.; Nezu, J.; Uchino, H.; Sai, Y.; Oku, A.; Shimane, M.; Tsuji, A. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun., 2000, 273(1), 251-260. (Pubitemid 30426895)
58. Pizzagalli, F.; Hagenbuch, B.; Stieger, B.; Klenk, U.; Folkers, G.; Meier, P.J. Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol. Endocrinol., 2002, 10, 2283-96. (Pubitemid 35155540)
59. van der Deure, W.M.; Appelhof, B.C.; Peeters, R.P.; Wiersinga, W.M.; Wekking, E.M.; Huyser, J.; Schene, A.H.; Tijssen, J.G.; Hoogendijk, W.J.; Visser, T.J.; Fliers, E. Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients. Clin. Endocrinol. (Oxf)., 2008, 69(5), 804-811.
60. Nomura, T.; Lu, R.; Pucci, M.L.; Schuster, V.L. The two-step model of prostaglandin signal termination: In vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase. Mol. Pharmacol. , 2004, 65(4), 973-978. (Pubitemid 38420503)
61. Chi, Y; Pucci, M.L.; Schuster, V.L. Dietary salt induces transcription of the prostaglandin transporter gene in renal collecting ducts. Am. J. Physiol. Renal Physiol., 2008, 295(3), F765-71.
62. Holla, V.R.; Backlund, M.G.; Yang, P.; Newman, R.A.; DuBois, R.N. Regulation of prostaglandin transporters in colorectal neoplasia. Cancer Prev. Res., 2008, 1, 93-99.
63. Pomari, E.; Nardi, A.; Fiore, C.; Celeghin, A.; Colombo, L.; Dalla Valle, L. Transcriptional control of human organic anion transporting polypeptide 2B1 gene. J. Steroid. Biochem. Mol. Biol., 2009, 115(3-5), 146-152.
64. Kullak-Ublick, G.A.; Ismair, M.G.; Stieger, B.; Landmann, L.; Huber, R.; Pizzagalli, F.; Fattinger, K.; Meier, P.J.; Hagenbuch, B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology, 2001, 120(2), 525-533. (Pubitemid 32147650)
65. Pizzagalli, F.; Varga, Z.; Huber, R.D.; Folkers, G.; Meier, P.J.; St- Pierre, M.V. Identification of steroid sulfate transport processes in the human mammary gland. J. Clin. Endocrinol. Metab., 2003, 88(8):3902-3912. (Pubitemid 37034545)
66. Niessen, J.; Jedlitschky, G.; Grube, M.; Bien, S.; Schwertz, H.; Ohtsuki, S.; Kawakami, H.; Kamiie, J.; Oswald, S.; Starke, K.; Strobel, U.; Siegmund, W.; Rosskopf, D.; Greinacher, A.; Terasaki, T; Kroemer, HK. Human platelets express organic aniontransporting peptide 2B1, an uptake transporter for atorvastatin. Drug Metab. Dispos., 2009, 37(5), 1129-1137.
67. Grube, M.; Reuther, S.; Meyer Zu Schwabedissen, H.; Köck, K.; Draber, K.; Ritter, C.A.; Fusch, C.; Jedlitschky, G.; Kroemer, H.K. Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta. Drug Metab. Dispos., 2007, 35(1), 30-35. (Pubitemid 46036473)
68. Le Vee, M.L.; Lecureur, V.; Stieger, B.; Fardel, O. Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin- 6. Drug Metab. Dispos., 2009, 37, 685-93.
69. Bronger, H.; König, J.; Kopplow, K; Steiner, H.H.; Ahmadi, R.; Herold-Mende, C.; Keppler, D.; Nies, A.T. ABC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res., 2005, 5(24), 11419-11428. (Pubitemid 41821699)
70. Adachi, H.; Suzuki, T.; Abe, M.; Asano, N.; Mizutamari, H.; Tanemoto, M.; Nishio, T.; Onogawa, T.; Toyohara, T.; Kasai, S.; Satoh, F.; Suzuki, M.; Tokui, T.; Unno, M.; Shimosegawa, T.; Matsuno, S.; Ito, S.; Abe, T. Molecular characterization of human and rat organic anion transporter OATP-D. Am. J. Physiol. Renal Physiol., 2003, 285(6), F1188-97. (Pubitemid 37421055)
71. Huber, R.D.; Gao, B.; Sidler Pfändler, M.A.; Zhang-Fu, W.; Leuthold, S.; Hagenbuch, B.; Folkers, G.; Meier, P.J.; Stieger, B. Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain. Am. J. Physiol. Cell Physiol., 2007, 292(2), C795-806.
72. Fujiwara, K.; Adachi, H.; Nishio, T.; Unno, M.; Tokui, T.; Okabe, M.; Onogawa, T.; Suzuki, T.; Asano, N.; Tanemoto, M.; Seki, M.; Shiiba, K.; Suzuki, M.; Kondo, Y.; Nunoki, K.; Shimosegawa, T.; Iinuma, K.; Ito, S.; Matsuno, S.; Abe, T. Identification of thyroid hormone transporters in humans: Different molecules are involved in a tissue-specific manner. Endocrinology, 2001, 142(5), 2005-2012. (Pubitemid 32405959)
73. Wojtal, K.A.; Eloranta, J.J.; Hruz, P.; Gutmann, H.; Drewe, J.; Staumann, A.; Beglinger, C.; Fried, M.; Kullak-Ublick, G.A.; Vavricka, S.R. Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug. Metab. Dispos., 2009 , 37(9), 1871-1877.
74. Ancona, N.; Maglietta, R.; Piepoli, A.; D 'Addabbo, A.; Cotugno, R.; Savino, M.; Liuni, S.; Carella, M.; Pesole, G.; Perri, F. On the statistical assessment of classifiers using DNA microarray data. BMC Bioinformatics, 2006, 197,387.
75. Sainis, I.; Fokas, D.; Vareli, K.; Tzakos, A.G.; Kounnis, V.; Briasoulis, E. Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs. Mar. Drugs, 2010, 8(3), 629-657.
76. Yamaguchi, H.; Sugie, M.; Okada, M.; Mikkaichi, T; Toyohara, T.; Abe, T.; Goto, J.; Hishinuma, T.; Shimada, M.; Mano, N. Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: Estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1. Drug Metab. Pharmacokinet., 2010, 25, 314-7.
77. Toyohara, T.; Suzuki, T.; Morimoto, R.; Akiyama, Y.; Souma, T.; Shiwaku, H.O.; Takeuchi, Y.; Mishima, E.; Abe, M.; Tanemoto, M.; Masuda, S.; Kawano, H.; Maemura, K.; Nakayama, M.; Sato, H.; Mikkaichi, T.; Yamaguchi, H.; Fukui, S.; Fukumoto, Y.; Shimokawa, H.; Inui, K.; Terasaki, T.; Goto, J.; Ito, S.; Hishinuma, T.; Rubera, I.; Tauc, M.; Fujii-Kuriyama, Y.; Yabuuchi, H.; Moriyama, Y.; Soga, T.; Abe, T. SLCO4C1 transporter eliminates uremic toxins andattenuates hypertension and renal inflammation. J. Am. Soc. Nephrol., 2009, 20(12), 2546-2555.
78. Okabe, M.; Szakács, G.; Reimers, M.A.; Suzuki, T.; Hall, M.D.; Abe, T.; Weinstein, J.N.; Gottesman, M.M. Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters. Mol. Cancer Ther., 2008, 7(9), 3081-3091.
79. Wlcek, K.; Svoboda, M.; Thalhammer, T.; Sellner, F.; Krupitza, G.; Jaeger, W. Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma. Cancer Biol. Ther., 2008, 7(9), 1450-5.
80. Liedauer, R.; Svoboda, M.; Wlcek, K.; Arrich, F.; Jäger, W.; Toma, C.; Thalhammer, T.Different expression patterns of organic anion transporting polypeptides in osteosarcomas, bone metastases and aneurysmal bone cysts. Oncol. Rep., 2009, 22(6), 1485-92.
81. http://www.proteinatlas.org/tissue-profile.php?antibody-id=25062
82. Isidor, B.; Pichon, O.; Redon, R.; Day-Salvatore, D.; Hamel, A.; Siwicka, K.A.; Bitner-Glindzicz, M.; Heymann, D.; Kjellén, L.; Kraus, C.; Leroy, J.G.; Mortier, G.R.; Rauch, A.; Verloes, A.; David, A.; Le Caignec, C. Mesomelia-synostoses syndrome results from deletion of SULF1 and SLCO5A1 genes at 8q13. Am. J. Hum. Genet., 2010, 87(1), 95-100.
83. Suzuki, T; Onogawa, T.; Asano, N.; Mizutamari, H.; Mikkaichi, T.; Tanemoto, M.; Abe, M.; Satoh, F.; Unno, M.; Nunoki, K.; Suzuki, M.; Hishinuma, T.; Goto, J.; Shimosegawa, T.; Matsuno, S.; Ito, S.; Abe, T. Identification and characterization of novel rat and human gonad-specific organic anion transporters. Mol. Endocrinol., 2003, 17(7), 1203-15. (Pubitemid 36819945)
84. Lee, S.Y.; Williamson, B.; Caballero, O.L.; Chen, Y.T.; Scanlan, M.J.; Ritter, G.; Jongeneel, C.V.; Simpson, A.J.; Old, L.J. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/ testis (CT) antigen expressed in human lung cancer. Cancer Immun., 2004, 17, 4, 13.
85. Oba-Shinjo, S.M.; Caballero, O.L.; Jungbluth, A.A.; Rosemberg, S.; Old, L.J.; Simpson, A.J.; Marie, S.K. Cancer-testis (CT) antigen expression in medulloblastoma. Cancer Immun., 2008, 22, 8, 7.
86. Hilgendorf, C.; Ahlin, G.; Seithel, A.; Artursson, P.; Ungell, A.L.; Karlsson, J. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab. Dispos., 2007, 35(8), 1333-1340. (Pubitemid 47121774)
87. Endter, S.; Francombe, D.; Ehrhardt, C.; Gumbleton, M. RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models. J. Pharm. Pharmacol., 2009, 61(5), 583-591.
88. Gao, B.; Huber, R.D.; Wenzel, A.; Vavricka, S.R.; Ismair, M.G.; Remé, C.; Meier, P.J. Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium. Exp. Eye Res., 2005, 80(1), 61-72. (Pubitemid 40126514)
89. Wlcek, K.; Svoboda, M.; Riha, J.; Zakaria, S.; Olszewski U.; Dvorak, Z.; Sellner, F.; Ellinger, I.; Jäger, W.; Thalhammer, T. The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer. Cancer Biol. Ther., 2011, 11(9).
90. Kindla, J.; Rau, T.T.; Jung, R.; Fasching, P.A.; Strick, R.; Stoehr, R.; Hartmann, A.; Fromm, M.F.; König, J. Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissue. Cancer Biol. Ther., 2011, 11(6).
91. Tirona RG, Leake BF, Wolkoff AW, Kim RB. Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J. Pharmacol. Exp. Ther., 2003, 304(1), 223-228. (Pubitemid 36008932)
92. Meyer Zu Schwabedissen, H.E.; Tirona, R.G.; Yip, C.S.; Ho, R.H.; Kim, R.B. Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res., 2008, 68(22), 9338-9347.
93. Meyer Zu Schwabedissen; H.E.; Kim, R.B. Hepatic OATP1B transporters and nuclear receptors PXR and CAR: Interplay, regulation of drug disposition genes, and single nucleotide polymorphisms. Mol. Pharm., 2009; 6, 1644-1661.
94. Meyer Zu Schwabedissen, H.E.; Böttcher, K.; Chaudhry, A.; Kroemer, H.K.; Schuetz, E.G.; Kim, R.B. Liver X receptor ř and farnesoid X receptor are major transcriptional regulators of OATP1B1. Hepatology, 2010, 52, 1797-1807.
95. Klaassen, C.D.; Slitt, A.L. Regulation of hepatic transporters by xenobiotics receptors. Curr. Drug Metab., 2005, 6(4), 309-28. (Pubitemid 41086765)
96. Teng, S.; Piquette-Miller, M. Regulation of transporters by nuclear hormone receptors: Implications during inflammation. Mol. Pharm., 2008, 5(1), 67-76. (Pubitemid 351300036)
97. Mottino, A.D.; Catania, V.A. Hepatic drug transporters and nuclear receptors: Regulation by therapeutic agents. World J. Gastroenterol., 2008, 14(46), 7068-74.
98. Cheng, X; Klaassen, C.D. Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. Drug Metab Dispos., 2009, 37(11), 2178-2185.
99. Cheng, X.; Maher, J.; Dieter, M.Z.; Klaassen, C.D. Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways. Drug Metab. Dispos., 2005, 33,1276-1282. (Pubitemid 41196968)
100. Cheng, X.; Maher, J.; Lu, H.; Klaassen, C.D. Endocrine regulation of gender-divergent mouse organic anion-transporting polypeptide (Oatp) expression. Mol. Pharmacol., 2006, 70(4), 1291-1297. (Pubitemid 44435981)
101. Miki, Y., Suzuki, T., Kitada, K., Yabuki, N., Shibuya, R., Moriya, T., Ishida, T., Ohuchi, N., Blumberg, B., Sasano, H. Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res., 2006, 66, 535-542. (Pubitemid 43168338)
102. Olinga, P.; Elferink, M.G.; Draaisma, A.L.; Merema, M.T.; Castell, J.V.; Pérez, G.; Groothuis, GM. Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. Eur. J. Pharm. Sci., 2008, 33(4-5), 380-389.
103. Jung, D.; Hagenbuch, B.; Gresh, L.; Pontoglio, M.; Meier, P.J.; Kullak-Ublick, G.A. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J. Biol .Chem., 2001, 276, 37206-37214
104. Furihata, T.; Satoh, T.; Yamamoto, N.; Kobayashi, K.; Chiba, K. Hepatocyte nuclear factor 1 alpha is a factor responsible for the interindividual variation of OATP1B1 mRNA levels in adult Japanese livers. Pharm. Res., 2007, 24, 2327-2332. (Pubitemid 350060721)
105. Jung, D.; Elferink, M.G.; Stellaard, F.; Groothuis, G.M. Analysis of bile acid-induced regulation of FXR target genes in human liver slices. Liver Int., 2007, 27, 137-144. (Pubitemid 46139438)
106. Jigorel, E.; Le Vee, M.; Boursier-Neyret, C.; Parmentier, Y.; Fardel, O. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drugsensing receptors in primary human hepatocytes. Drug Metab. Dispos., 2006, 34, 1756-1763. (Pubitemid 44427479)
107. Cui,Y.J.; Aleksunes, L.M.; Tanaka, Y.; Goedken, M.J.; Klaassen, C.D. Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. Toxicol. Sci., 2009, 110(1), 47-60.
108. Donner, M.G.; Schumacher, S.; Warskulat, U.; Heinemann, J.; Häussinger, D. Obstructive cholestasis induces TNF-alpha- and IL- 1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 293, G1134-1146. (Pubitemid 350255054)
109. Stedman, C.A.; Liddle, C.; Coulter, S.A.; Sonoda, J.,; Alvarez, J.G.; Moore, D.D.,; Evans, R.M.; Downes, M. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury. Proc. Natl. Acad. Sci. U S A, 2005, 8, 102, 2063-2068. (Pubitemid 40262012)
110. Lickteig, A.J.; Slitt, A.L.; Arkan, M.C.; Karin, M.; Cherrington, N.J. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha,interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug. Metab. Dispos., 2007, 35, 402-409. (Pubitemid 46333903)
111. Cherrington NJ, Slitt AL, Li N, Klaassen CD. Lipopolysaccharidemediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos., 2004, 32,734-741. (Pubitemid 38821875)
112. Rost, D.; Herrmann, T.; Sauer; P.; Schmidts, HL.; Stieger, B.; Meier, PJ.; Stremmel, W.; Stiehl, A. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: Effect of ursodeoxycholate. Hepatolog, 2003, 38, 187-95. (Pubitemid 36775810)
113. Gartung, C; Matern, S. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis. Yale J. Biol. Med., 1997, 70, 355-63. (Pubitemid 28262251)
114. Hartmann, G.; Cheung, A.K.; Piquette-Miller, M. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J. Pharmacol. Exp. Ther., 2002, 303, 273-281.
115. Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, LorenzenJ, Matern S, Gartung C. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 2003, 38 (2):345-354. (Pubitemid 36919855)
116. Petrovic, V.; Wang, J.H.; Piquette-Miller, M. Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats. Drug Metab. Dispos., 2008, 36, 1944-1950.
117. Le Vee, M.; Jouan, E.; Moreau, A.; Fardel, O. Regulation of drug transporter mRNA expression by interferon-gamma in primary human hepatocytes. Fundam. Clin. Pharmacol., 2010, Feb 22.
118. Le Vee, M.; Gripon,.P.; Stieger, B.; Fardel, O. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab. Dispos. , 2008, 36, 217-222. (Pubitemid 351185762)
119. Ogasawara, K.; Terada, T.; Katsura, T.; Hatano, E.; Ikai, I.; Yamaoka, Y.; Inui, K. Hepatitis C virus-related cirrhosis is a major determinant of the expression levels of hepatic drug transporters. Drug Metab. Pharmacokinet., 2010, 25(2), 190-199.
120. Lu, R.; Kanai, N.; Bao, Y.; Wolkoff, A.W.; Schuster, V.L. Regulation of renal oatp mRNA expression by testosterone. Am. J. Physiol., 1996, 270(2 Pt 2), F332-337.
121. Meliá, M.J.; Bofill, N.; Hubank, M.; Meseguer, A. Identification of androgen-regulated genes in mouse kidney by representational difference analysis and random arbitrarily primed polymerase chain reaction. Endocrinology, 1998, 139, 688-695. (Pubitemid 28513220)
122. Wood, M.; Ananthanarayanan, M.; Jones, B.; Wooton-Kee, R.; Hoffman, T.; Suchy, F.J.; Vore, M. Hormonal regulation of hepatic organic anion transporting polypeptides. Mol. Pharmacol., 2005, 68, 218-225. (Pubitemid 41002961)
123. Aleksunes, L.M.; Augustine, L.M.; Scheffer, G.L.; Cherrington, N.J.; Manautou, J.E. Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment. Toxicology, 2008, 250(2-3), 82-88.
124. Sun, H.; Liu, L.; Pang, K.S. Increased estrogen sulfation of estradiol 17beta-D-glucuronide in metastatic tumor rat livers. J. Pharmacol. Exp. Ther,. 2006, 319, 818-831.
125. Kulis, M.; Esteller, M. DNA methylation and cancer. Adv. Genet., 2010, 70, 27-56.
126. Imai, S.; Kikuchi, R.; Kusuhara, H.; Yagi, S.; Shiota, K.; Sugiyama, Y. Analysis of DNA-methylation and histone modification profiles of liver-specific transporters. Mol.Pharmacol., 2009, 75, 568-576.
127. Ichihara, S.; Kikuchi, R.; Kusuhara, H.; Imai, S.; Maeda, K.; Sugiyama, Y. DNA-methylation profiles of organic anion transporting polypeptide 1B3 in cancer cell lines. Pharm. Res., 2010, 27, 510-516.
128. Jacquemin, E.; Hagenbuch, B.; Stieger, B.; Wolkoff, A.W.; Meier, P.J. Expression cloning of a rat liver Na(+)-independent organic anion transporter. Proc. Natl. Acad. Sci. USA, 1994, 91,133-137. (Pubitemid 24018657)
129. Lee, T.K.; Koh, A.S.; Cui, Z.; Pierce, R.H.; Ballatori, N. Nglycosylation controls functional activity of Oatp1, an organic anion transporter. Am. J. Physiol. Gastrointest. Liver Physiol., 2003, 285, G371-381. (Pubitemid 36875209)
130. Guo, G.L.; Klaassen, C.D. Protein kinase C suppresses rat organic anion transporting polypeptide 1- and 2-mediated uptake. J. Pharmacol. Exp. Ther., 2001, 299, 551-557. (Pubitemid 32979667)
131. Xiao, Y.; Nieves, E.; Angeletti, R.H.; Orr, G.A.; Wolkoff, A.W. Rat organic anion transporting protein 1A1 (Oatp1a1): Purification and phosphopeptide assignment. Biochemistry, 2006, 45, 3357-3369. (Pubitemid 43376354)
132. Köck, K.; Koenen, A.; Giese, B.; Fraunholz, M.; May, K.; Siegmund, W.; Hammer, E.; Völker, U.; Jedlitschky, G.; Kroemer, H.K.; Grube, M. Rapid modulation of the organic anion transporting polypeptide 2B1 (OATP2B1, SLCO2B1) function by protein kinase C-mediated internalization. J. Biol. Chem., 2010, 285, 11336-47.
133. Congiu, M.; Mashford, M.L.; Slavin, J.L.; Desmond, P.V. Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease. J. Gastroenterol. Hepatol,. 2009, 24(6), 1038-1044.
134. Spence, R.; Mandagere, A.; Richards, D.B.; Magee, M.H.; Dufton, C.; Boinpally, R. Potential for pharmacokinetic interactions between ambrisentan and cyclosporine. Clin. Pharmacol. Ther., 2010, 88(4), 513-520.
135. Treiber, A.; Schneiter, R.; Häusler, S.; Stieger, B. Bosentan is a substrate of human OATP1B1 and OATP1B3: Inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab. Dispos., 2007, 35(8), 1400-1407 (Pubitemid 47121782)
136. Rodrigues, A.C. Efflux and uptake transporters as determinants of statin response. Expert. Opin. Drug. Metab. Toxicol., 2010, 6(5), 621-32.
137. Gui, C.; Miao, Y., Thompson, L; Wahlgren, B.; Mock, M.; Stieger, B. Hagenbuch, B. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. Eur. J. Pharmacol., 2008, 14, 584, 57-65.
138. Campbell, S.D.; de Morais S.M.; Xu, J. J. Inhibition of human organic anion transporting polypeptide OATP1B1 as a mechanism of drug-induced hyperbilirubinemia. Chem. Biol. Interact., 2004; 150; 179-187. (Pubitemid 39463281)
139. Westholm,D.E.; Salo, D.R.; Viken, K.J.; Rumbley, J.N.; Anderson, G.W. The blood-brain barrier thyroxine transporter organic aniontransporting polypeptide 1c1 displays atypical transport kinetics. Endocrinolog, 2009, 150(11), 5153-5162.
140. Evers, R.; Chu, X.Y. Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity. Mol. Pharmacol., 2008, 74(2), 309-311.
141. Zaher, H.; zu Schwabedissen, H.E.; Tirona, R.G.; Cox, M.L.; Obert, L.A.; Agrawal, N.; Palandra, J.; Stock, J.L.; Kim, R.B.; Ware, J.A. Targeted disruption of murine organic aniontransporting polypeptide1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin. Mol. Pharmacol., 2008, 74, 320-329.
142. Lu, H.; Choudhuri, S.; Ogura, K.; Csanaky, I.L.; Lei, X.; Cheng, X., Song, P., Klaassen, C. Characterization of organic anion transporting polypeptide 1b2-null mice: Essential role in hepatic uptake/ toxicity of phalloidin and microcystin-LR. Toxicol. Sci., 2008, 103, 35-45. (Pubitemid 351524475)
143. Chen, C.; Stock, J.L.; Liu, X.; Shi, J; Van Deusen, J.W.; DiMattia, D.A.; Dullea, R.G., deMorais, S.M. Utility of a novel Oatp1b2 knockout mouse model for evaluating the role of Oatp1b2 in the hepatic uptake of model compounds. Drug Metab. Dispos., 2008, 36, 1840-1845.
144. van de Steeg, E.; van der Kruijssen, C.M.; Wagenaar, E.; Burggraaff, J.E.; Mesman, E.; Kenworthy, K.E.; Schinkel, A.H. Methotrexate pharmacokinetics in transgenic mice with liverspecific expression of human organic anion-transporting polypeptide 1B1(SLCO1B1). Drug Metab. Dispos., 2009, 37, 277-281.
145. van de Steeg, E.; Wagenaar, E.; van der Kruijssen, C.M.; Burggraaff, J.E.; de Waart, D.R.; Elferink, R.P.; Kenworthy, K.E.; Schinkel, A.H. Organic anion transporting polypeptide 1a/1bknockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs. J. Clin. Invest., 2010, 120, 2942-2952.
146. Shugarts, S.; Benet, L.Z. The role of transporters in the pharmacokinetics of orally administered drugs. Pharm. Res., 2009, 26(9), 2039-2054.
147. König, J.; Seithel, A.; Gradhand, U.; Fromm, M.F. Pharmacogenomics of human OATPtransporters. Naunyn Schmiedebergs Arch. Pharmacol., 2006, 372(6), 432-443.
148. Maeda, K.; Sugiyama, Y. Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs. Drug Metab. Pharmacokinet., 2008, 23(4), 223-235.